Novo Nordisk (NYSE: NVO), the Danish company best known as the maker of weight loss drug Wegovy, expanded a little on the ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

NEW YORK, NY / ACCESS Newswire / March 18, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors ...

Fast Company's annual list of the World's Most Innovative Companies spotlights organizations across various industries that are driving meaningful change through groundbreaking ideas and ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

We don’t think it is a coincidence that Americans have been consuming less junk food ever since the FDA approved the use of the GLP-1 drugs made by pharmaceutical giants Eli Lilly (Zepbound ) and Novo ...

Novo Nordisk rejoined the ABPI after a two-year suspension linked to promotional concerns. Audits confirmed compliance with ...

Medications like Ozempic and Mounjaro work by mimicking naturally occurring hormones in the body, such as glucagon-like ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Key Takeaways Novo Nordisk shares gained Monday as the company said it would present new data on the ability of semaglutide, ...